Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Case Reports in Obstetrics and Gynecology|March 20, 2018
Paraurethral Leiomyoma as an Incidental Finding in Patient with Fibroid UterusDmitry Fridman, Marnie Abeshouse, Alexander Sankin
Urologic Oncology|May 20, 2019
Human urothelial bladder cancer generates a clonal immune response: The results of T-cell receptor sequencingAlexander Sankin, Damini Chand, Mark Schoenberg, et al.
Urology|September 30, 2025
Urology Autonomy Maps: Evaluation of Attending Surgeon Expectations for Resident Competencies in Common Urology ProceduresDavid G Hanelin, Jonah Tripp, Alexander Sankin, et al.
Oncotargets and Therapy|May 9, 2022
The Development of Non-Invasive Diagnostic Tools in Bladder CancerAlison Schulz, Justin Loloi, Luis Pina Martina, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|March 10, 2011
Rate of renal cell carcinoma subtypes in different racesAlexander Sankin, Jacob Cohen, Hongbei Wang, et al.
Frontiers in Oncology|April 24, 2015
Metastatic non-clear cell renal cell carcinoma: an evidence based review of current treatment strategiesAlexander Sankin, A Ari Hakimi, James J Hsieh, et al.
BMC Surgery|March 7, 2021
Methodology for triage of urologic surgical cases in the setting of a pandemicAhmed Aboumohamed, Josh Gottlieb, Matthew DeMasi, et al.
Urology|August 4, 2012
Assessing renal function after partial nephrectomy using renal nuclear scintigraphy and estimated glomerular filtration rateAlexander Sankin, John P Sfakianos, Jeffrey Schiff, et al.
Urologic Oncology|May 13, 2017
The expanding repertoire of targets for immune checkpoint inhibition in bladder cancer: What lies beneath the tip of the iceberg, PD-L1Alexander Sankin, Deepa Narasimhulu, Peter John, et al.
Genes & Diseases|April 20, 2026
Immune checkpoint B7x promotes immune evasion and resistance to PD-1/PD-L1 blockade in bladder cancerMarc C Pulanco, Xiang Yu Zheng, Alexander Sankin, et al.
Pageof 4